EM1903H "Kidney Cancer Program: Striving for Excellence" (IM GR-030819)
To discuss advances made by the Kidney Cancer Program to the diagnosis and treatment of kidney cancer
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Assess the impact of the molecular genetics of kidney cancer.
- Understand the spectrum of metastatic kidney cancer.
- Make informed decisions about patients with brain metastases.
- Comment on the emerging role of stereotactic radiation for kidney cancer.
James Brugarolas, M.D., Ph.D.
Director, Kidney Cancer Program
Sherry Wigley Crow Endowed Chair in Cancer Research
Professor, Internal Medicine
Division of Hematology/Oncology
- 1.00 AMA